NCT01595360

Safety, Tolerability and Efficacy Study of TT-173 in Healthy Volunteers After Tooth Extraction

A Phase 1, Randomized, Open, Controlled, Comparative Safety, Tolerability and Efficacy Study of TT-173 in Healthy Volunteers After Tooth Extraction

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Thrombotargets Europe S.L · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the safety, tolerability and efficacy of TT-173 in healthy volunteers after tooth extraction.

Detailed description

As the TT-113 has been cleared for use as a topical hemostatic agent, the proposed study will further investigate the safety, tolerability and efficacy of TT-113 in healthy volunteers after tooth extraction.

Conditions

• Tooth Extraction

Interventions

Type	Name	Description
DRUG	Placebo	It is applied directly to the bleeding site after tooth extraction
DRUG	TT-173	It is applied directly to the bleeding site after tooth extraction

Timeline

• Start date: 2012-04-01
• Primary completion: 2013-09-01
• Completion: 2013-09-01
• First posted: 2012-05-10
• Last updated: 2013-09-16

Locations

1 site across 1 country: Spain